June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Expression of fibrotic and inflammation markers in the human glaucomatous optic nerve head
Author Affiliations & Notes
  • Oliver W Gramlich
    Dept. of Ophthalmology & Visual Sciences, The University of Iowa, Iowa City, Iowa, United States
    Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care, Iowa City, Iowa, United States
  • Dina F Ahram
    Dept. of Ophthalmology & Visual Sciences, The University of Iowa, Iowa City, Iowa, United States
  • Markus H Kuehn
    Dept. of Ophthalmology & Visual Sciences, The University of Iowa, Iowa City, Iowa, United States
    Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care, Iowa City, Iowa, United States
  • Footnotes
    Commercial Relationships   Oliver Gramlich, None; Dina Ahram, None; Markus Kuehn, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 4918. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Oliver W Gramlich, Dina F Ahram, Markus H Kuehn; Expression of fibrotic and inflammation markers in the human glaucomatous optic nerve head
      . Invest. Ophthalmol. Vis. Sci. 2017;58(8):4918.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Structural and compositional changes of the optic nerve head (ONH) are a hallmark of glaucoma. This study aims to compare gene expression profiles in ONHs of human donors with primary open angle glaucoma (POAG) and unaffected controls to identify pathways functionally related to tissue remodeling and inflammation.

Methods : ONHs were collected from patients with clinically confirmed POAG (n=6) and age-matched control donors (n=6). RNA was extracted from ONHs and assayed using Affymetrix Human Exon 1.0 ST arrays. Differentially expressed genes in glaucoma versus control were identified by ANOVA. Quantitative RT-PCR and immunohistochemistry were performed to validate selected differentially expressed genes.

Results : Microarray analysis revealed 144 genes with reduced and 225 genes with elevated expression in ONHs of POAG donors when compared to controls. Pathway analysis indicates that many of these genes are functionally related to tissue remodeling (43 genes; p=0.015), proliferation (15 genes; p=0.045) and cellular inflammation (5 genes; p=0.028). PTGS2, CMKlR1, NMI, ITGBL1 and FBLN5 are representative markers of these groups and their heightened expression in POAG was verified by RT-PCR (1.2 to 5.4 fold increase). Immunohistochemistry indicated increased expression of FBLN5 as well as signs of cellular infiltrates in the nerve fiber layer and the lamina cribosa of glaucomatous ONHs.

Conclusions : As expected, the glaucomatous changes to the human ONH are associated with altered expression levels of a large number of genes. Interestingly, our data suggest increased expression of both inflammation-related genes and those associated with a fibrotic response. These processes have frequently been observed in concert with one another during CNS injury and are capable of reciprocal stimulation. Fibrosis can engender changes in the biophysical properties of the glaucomatous ONH and will present a barrier to axonal regeneration. The degree to which these events contribute to glaucomatous damage remains to be examined.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×